首页 / 多肽产品 / G(123种) / 人胃抑素 / (Pro3) Gastric Inhibitory Peptide (GIP), human
筛选
目录肽(按字母分类)
非天然氨基酸及其它砌块合成
(Pro3) Gastric Inhibitory Peptide (GIP), human
名称
(Pro3) Gastric Inhibitory Peptide (GIP), human
分子结构式
CAS号
299898-52-5
分子式
C226H338N60O64S
分子量
4951.53
作用靶点
Insulin Receptor
序列号
Tyr-Ala-Pro-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln
短序列号
YAPGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
纯度
≥95%
引用文献
[1]. Victor A Gault, et al. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes. Diabetes. 2005 Aug;54(8):2436-46. [2]. A H Sparre-Ulrich, et al. Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors. Br J Pharmacol. 2016 Jan;173(1):27-38.
* 本公司网站所有产品用于科学研究,不能用于人体
产品详情
数据下载

(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes.